Press Releases
October 15, 2026
Claris Biotherapeutics to Host Virtual KOL Event on Positive CSB-001 Data and the Unmet Need in Limbal Stem Cell Deficiency (LSCD)
October 11, 2026
Claris Biotherapeutics Releases Positive CSB-001 Clinical Proof-of-Concept Data in Limbal Stem Cell Deficiency at AAO 2026 Annual Meeting
September 29, 2026
Claris Bio Announces Oral Presentations at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting and Eyecelerator @ AAO
September 24, 2026
Claris Bio Establishes Corporate Headquarters in San Francisco
September 3, 2026
Claris Bio to Participate in Upcoming Investor Conferences